Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study.
about
Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?Increased ventricular cerebrospinal fluid lactate in depressed adolescentsTime-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidatesBrain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly.Mitochondrial dysfunction in bipolar disorder.In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings.In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders.Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.Leukocyte mitochondrial DNA copy number in blood is not associated with major depressive disorder in young adultsSex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in ratsReview: magnetic resonance spectroscopy studies of pediatric major depressive disorderA potential role for creatine in drug abuse?Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness.Decreased frontal lobe function in people with Internet addiction disorder.Pulsed light irradiation improves behavioral outcome in a rat model of chronic mild stress.A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.The other, forgotten genome: mitochondrial DNA and mental disorders.Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.Creatine supplementation associated or not with strength training upon emotional and cognitive measures in older women: a randomized double-blind studyAffective disorders, antidepressant drugs and brain metabolism.Glutamate metabolism in major depressive disorderReview of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesisA preliminary evaluation of the correlation between regional energy phosphates and resting state functional connectivity in depression.A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies.Incidence of major depressive episode correlates with elevation of substate region of residence.Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy studyCreatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot StudyMR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases.Energetic and cell membrane metabolic products in patients with primary insomnia: a 31-phosphorus magnetic resonance spectroscopy study at 4 tesla.Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment.Tissue-specific differences in brain phosphodiesters in late-life major depressionCreatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression.Purinergic signaling and energy homeostasis in psychiatric disordersLateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study.Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner.Impaired mitochondrial function in psychiatric disorders.A mitochondrial bioenergetic basis of depression.An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women.The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence.
P2860
Q24631151-B18C0EA6-151D-4572-B49C-1A7784C89419Q28834690-ED21CA1D-6B11-4577-B273-F7ACE514BA18Q30423149-0B338EB8-D9D0-44C9-91C9-5B610B710667Q30585268-6D6EAE19-79B9-4B26-A43F-E5E1F8A7F062Q30640247-FED80F4C-6734-4CE1-84C8-6FEDC6D4FA6CQ30927398-15409263-3B04-474F-B2FE-819A532860FAQ30980756-73D5C943-E21F-4716-ABC0-0A384CA9875BQ32115381-27BAD9E8-80EC-4125-A2E8-ECD215C164DCQ33429548-433C2FB8-C070-4EB3-A234-2160292522F1Q33584175-0C0A2BAE-4948-4E0C-BA23-6FA2FF1A7445Q33771249-705BA238-1125-4B40-A973-7DF87FA4DE57Q33783427-20DBE250-66B1-4A5A-AD8C-EC7DA7F1BBC9Q33844763-337C60FB-DFEC-4072-821A-D06323E88303Q34084286-5D55CA9A-10B2-4973-B1DA-E8BA59EABE4DQ34095771-FCA8F5BB-C5A9-439C-A2C1-4A9E028BBCA1Q34158980-4284DB27-4E4D-40C7-B7E6-BDC2F8D95E09Q34292341-77AC1353-9F98-4B9B-A7B5-34D4FD725FEFQ34416941-F523C177-FF3C-4F4C-8B6B-55705682C3F2Q34674792-7459D103-A3CD-4DFC-8C45-BC7B18B06110Q35009362-4AB0A55E-060E-45F6-AD29-1599B5CC1642Q35204087-9A12FB09-6051-4402-AB4B-01579F12D72DQ35756139-17F5C322-B134-4B44-9959-EA24F67222A4Q35962076-D5C30E41-DC03-4750-A20C-1F1933C53E48Q36109932-1EFA7598-2FC5-4F01-BBE6-D97DFAE05055Q36119909-379C6AE0-E496-467B-954C-52B2871F81F1Q36263456-54C665AD-7827-47B1-8CF5-3FABBB9BA2D6Q36271087-96E6F710-E548-4960-AD4D-816EDFF6915EQ36387048-490329C0-4865-4092-A61B-97E6EBCEAF08Q36598509-26B401A9-FBF3-4C6B-BB35-FA488AD771F1Q36728449-681F1C72-D0E3-40EC-B35E-6C7B188B3818Q37054253-548931D3-7874-4637-A0FD-8AAA20395327Q37110292-3126C860-33FF-4A55-8A70-7339DC0F6BAAQ37153400-063E850E-8D9C-48FE-993F-FBC20DD0F118Q37284060-9CFC30D5-D448-4C93-8EB6-2626DF22C7BFQ37415382-724904EF-19AC-4B2D-A29D-513852D02FDDQ37480270-F6CB6522-623F-4A07-9C88-71B4D1CEB841Q38003304-94A7D785-69E3-41E1-8148-B825F957578BQ38254909-408EDFAB-3174-4199-9971-9E93DFC043CAQ38645491-CB5F5FF1-356E-4350-B5E4-112EAC288620Q38924121-CDF376E6-2B5C-4B68-9028-481EBC3B4963
P2860
Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Lower levels of nucleoside tri ...... resonance spectroscopy study.
@en
Lower levels of nucleoside tri ...... resonance spectroscopy study.
@nl
type
label
Lower levels of nucleoside tri ...... resonance spectroscopy study.
@en
Lower levels of nucleoside tri ...... resonance spectroscopy study.
@nl
prefLabel
Lower levels of nucleoside tri ...... resonance spectroscopy study.
@en
Lower levels of nucleoside tri ...... resonance spectroscopy study.
@nl
P2093
P356
P1476
Lower levels of nucleoside tri ...... resonance spectroscopy study.
@en
P2093
P304
P356
10.1176/AJP.154.1.116
P407
P577
1997-01-01T00:00:00Z